our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 15 September 2014

    Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
  • 3 September 2014

    Antares Pharma to Present at the Morgan Stanley Healthcare Conference
  • 5 August 2014

    Antares Pharma Reports Second Quarter 2014 Operating and Financial Results
  • 31 July 2014

    Antares Pharma to Host Second Quarter 2014 Operating and Financial Results Conference Call
  • 22 July 2014

    Antares Pharma Annouces First Patient Dosed In Phase 3 QuickShot® Study Evaluating Testosterone-Deficient Adult Males
  • 25 June 2014

    Rapid Restoration and Consistent Maintenance of Steady Blood Levels Achieved With Once-Weekly Subcutaneous Administration of Testosterone Delivered With a Novel Auto Injector

latest products & technology


Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>